Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Lymphoblastic Leukemia
100%
Leukemic Cells
100%
Rat Model
100%
Leukemia
60%
Cyclophosphamide
40%
Cell Killing
40%
Inoculation
40%
Bone Marrow
20%
Liver
20%
Spleen
20%
Growth Pattern
20%
Autopsy
20%
Disease Stage
20%
Survival Time
20%
New Treatment Options
20%
Peripheral Blood
20%
Impaired Function
20%
Clonogenic
20%
Treatment Effect
20%
Lymphadenopathy
20%
Radiation Effects
20%
Radiosensitivity
20%
Transplantable
20%
Biological Properties
20%
Non-immunogenic
20%
Hemopoiesis
20%
Prominent Features
20%
Lymphocytic Leukemia
20%
Hepatosplenomegaly
20%
Severe Thrombocytopenia
20%
T-cell Leukemia
20%
Immature T Cells
20%
Gastrointestinal Hemorrhage
20%
Quantitative Estimation
20%
Severe Anemia
20%
Intravenous Inoculation
20%
Splenic Rupture
20%
Surviving Fraction
20%
Haemopoietic Tissue
20%
WAG/rij Rat
20%
Rupture Hemorrhage
20%
Inoculum
20%
Pulmonary Hemorrhage
20%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Leukemia
100%
Cyclophosphamide
100%
Disease
50%
Anemia
50%
Lymphoid Leukemia
50%
Hematopoiesis
50%
Lymphadenopathy
50%
Survival Time
50%
Thrombocytopenia
50%
Radiosensitivity
50%
Single Drug Dose
50%
Hepatosplenomegaly
50%
Adult T-Cell Leukemia/Lymphoma
50%
Gastrointestinal Bleeding
50%
Pulmonary Hemorrhage
50%
Spleen Rupture
50%
Log Cell Kill
50%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
100%
Acute Lymphoblastic Leukemia
100%
Leukemia
100%
Rat Model
100%
Disease
50%
Lymphatic Leukemia
50%
Anemia
50%
Thrombocytopenia
50%
Wistar Albino Glaxo Rat
50%
Survival Time
50%
T Cell Leukemia
50%
Hepatosplenomegaly
50%
Lymphadenopathy
50%
Lung Hemorrhage
50%
Gastrointestinal Hemorrhage
50%
Spleen Rupture
50%
Immunology and Microbiology
Rat Model
100%
Cyclophosphamide
100%
T Cell
50%
Radioresistance
50%
Hematopoiesis
50%
Survival Time
50%
Lymphadenopathy
50%
Log Cell Kill
50%
Wistar Albino Glaxo Rat
50%
Inoculum
50%